Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics - PubMed (original) (raw)
Review
Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics
Dennis J Selkoe et al. Annu Rev Pharmacol Toxicol. 2003.
Abstract
Degenerative diseases of the brain were long considered among the most obscure and intractable of human maladies. However, recent advances in understanding their mechanisms have brought us to the verge of potential disease-modifying agents. This progress is perhaps best exemplified by the case of Alzheimer's disease. The application of molecular pathology and genetics has led to the recognition that the four genes implicated to date in familial Alzheimer's disease all chronically elevate cerebral levels of the amyloid beta-protein (Abeta). Accordingly, small molecule inhibitors of the beta- and gamma-secretases, the proteases that generate Abeta from its precursor, are under active development, and some have shown in vivo efficacy in mouse models. An alternative approach, active or passive immunization against Abeta, has received extensive pre-clinical validation in mice, but an effective preparation free of significant side effects in humans is still awaited. Several other potential therapies are also reviewed here. If one or more of these varied approaches is ultimately proven to slow or prevent dementia, Alzheimer's disease will become a salient example of the successful application of reductionist biology to the most complex of organs, the human cerebral cortex.
Similar articles
- Alzheimer's disease.
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review. - The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.
Ling S, Zhou J, Rudd JA, Hu Z, Fang M. Ling S, et al. Anat Rec (Hoboken). 2011 Aug;294(8):1307-18. doi: 10.1002/ar.21425. Epub 2011 Jun 29. Anat Rec (Hoboken). 2011. PMID: 21717585 Review. - Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A. D'Onofrio G, et al. Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14. Expert Opin Drug Discov. 2012. PMID: 22468891 Review. - Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
Mitani Y, Yarimizu J, Akashiba H, Shitaka Y, Ni K, Matsuoka N. Mitani Y, et al. J Neurochem. 2013 May;125(3):465-72. doi: 10.1111/jnc.12125. Epub 2013 Jan 8. J Neurochem. 2013. PMID: 23240999 - [Aβ immunotherapy for Alzheimer's disease].
Sakai K, Yamada M. Sakai K, et al. Brain Nerve. 2013 Apr;65(4):461-8. Brain Nerve. 2013. PMID: 23568994 Review. Japanese.
Cited by
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.
Kumar M, Sharma AA, Datusalia AK, Khatik GL. Kumar M, et al. Med Chem. 2024;20(8):781-798. doi: 10.2174/0115734064295063240422100615. Med Chem. 2024. PMID: 38726789 Review. - Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.
Batko J, Antosz K, Miśków W, Pszczołowska M, Walczak K, Leszek J. Batko J, et al. Int J Mol Sci. 2024 Mar 17;25(6):3401. doi: 10.3390/ijms25063401. Int J Mol Sci. 2024. PMID: 38542375 Free PMC article. Review. - Neuroprotective Effects of N-methyl-(2S, 4R)-trans-4-hydroxy-L-proline (NMP) against Amyloid-β-Induced Alzheimer's Disease Mouse Model.
Ali J, Khan A, Park JS, Tahir M, Ahmad W, Choe K, Kim MO. Ali J, et al. Nutrients. 2023 Dec 1;15(23):4986. doi: 10.3390/nu15234986. Nutrients. 2023. PMID: 38068844 Free PMC article. - Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease.
Iyaswamy A, Thakur A, Guan XJ, Krishnamoorthi S, Fung TY, Lu K, Gaurav I, Yang Z, Su CF, Lau KF, Zhang K, Ng RC, Lian Q, Cheung KH, Ye K, Chen HJ, Li M. Iyaswamy A, et al. Signal Transduct Target Ther. 2023 Oct 23;8(1):404. doi: 10.1038/s41392-023-01657-4. Signal Transduct Target Ther. 2023. PMID: 37867176 Free PMC article. - Personalized Explanations for Early Diagnosis of Alzheimer's Disease Using Explainable Graph Neural Networks with Population Graphs.
Kim SY. Kim SY. Bioengineering (Basel). 2023 Jun 8;10(6):701. doi: 10.3390/bioengineering10060701. Bioengineering (Basel). 2023. PMID: 37370632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical